Dermavyx

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Dermavyx
Generic name: TRIAMCINOLONE ACETONIDE CREAM 0.1%, TRANSPARENT DRESSING
Manufacturer: V2 Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 47cd01ec-6675-4c5f-b69b-8ec87afb6034
SPL ID: 43db4a2a-38a3-4efd-827e-36b37089d1f1
Version: 1
Effective date: 2026-05-07
Source export date: 2026-10-12
Source partition: 14
Source file: https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/acb9b4700b9af1bdda1c389c7b35bfe38fd6d1a62aa48d17832812be4029b84f/drug-label-0014-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 03:12:10

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Dermavyx	openfda.brand_name
generic name		TRIAMCINOLONE ACETONIDE CREAM 0.1%, TRANSPARENT DRESSING	openfda.generic_name
manufacturer name		V2 Pharma, LLC	openfda.manufacturer_name
ndc	package	72835-777-02	openfda.package_ndc
ndc	package	16714-986-03	openfda.package_ndc
ndc	product	72835-777	openfda.product_ndc
ndc11	package	72835077702	derived:openfda.package_ndc
ndc11	package	16714098603	derived:openfda.package_ndc
rxcui		1014314	openfda.rxcui
spl id		43db4a2a-38a3-4efd-827e-36b37089d1f1	id
spl set id		47cd01ec-6675-4c5f-b69b-8ec87afb6034	set_id

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS: The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.